Clinical Pharmacology and Therapeutics.
Earlier clinical studies have shown that goldenseal inhibits cytochrome P450 and one study showed a 40 percent increase in the concentration of midazolam in the body.
Clinical studies and in vitro studies were conducted by the investigators to determine the relation between goldenseal and metformin.
They found that goldenseal has an effect on intestinal absorption of metformin and co-administration of metformin and goldenseal may compromise blood glucose control in patients with type 2 diabetes and increase their risk of negative health outcomes.
READ RELATED: Why Prescription Opioids Aren’t Only a Problem for White Americans
Paine said, “While this finding warrants a degree of caution to be exercised among patients and their treating physicians, we have more work to do to confirm whether these findings in healthy volunteers in fact have clinical relevance in the management of diabetes. We are in the process of starting a follow-up study that should ultimately answer that question.”
Source: Medindia
Source: